Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Genetic study identifies earliest-known dog, dating to 15,800 years ago - 2Ifo: Job cuts in Germany slowing but not enough for a turnaround
- 3Malaysian broadcaster rejects altered graphic about electricity rate hike
- 4Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
- 5the Wild in Style: The Reduced Portage Mustang's Bold Heritage
- Old age isn’t a modern phenomenon – many people lived long enough to grow old in the olden days, too
- American Airlines Flight Attendant Disappears Amid Layover in Colombia, Authorities Investigating
- Portugal among EU countries with the most people working close to 50 hours a week
- Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
- ‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
- Only 30% of young people in Israel optimistic about future, Aluma survey reveals
- NASA releases new photos of interstellar comet 3I/ATLAS
- Florence's Uffizi Gallery moves treasures to safety after cyberattack
